Clinical Trials Directory

Trials / Completed

CompletedNCT03099590

Alkontrol-herbal Effects on Alcohol Drinking

Alkontrol-herbal (Isoflavone) Effects on Alcohol Drinking in an Outpatient Setting

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
28 (actual)
Sponsor
Mclean Hospital · Academic / Other
Sex
All
Age
21 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Participants will enroll in a 14-week study (2 weeks of baseline, 8 weeks of treatment, and 4 weeks of follow-up) investigating the impact that Alkontrol-herbal (Isoflavone; Kudzu) has on alcohol intake in a population seeking treatment for an alcohol use disorder.

Detailed description

Over the past 15 years, the Behavioral Psychopharmacology Research Lab at McLean Hospital has extensively studied kudzu extract and demonstrated its safety and efficacy in healthy control subjects as well as in heavy binge drinkers. The relative success of our recent outpatient trial of kudzu extract demonstrated a modest decrease in drinking, reduction in the number of heavy drinking days, and significant increase in the number of days abstinent. This suggests that Alkontrol-herbal, kudzu extract, may be a useful adjunct in treating alcohol use disorders. Participants will enroll in a 14-week study (2 weeks of baseline, 8 weeks of treatment, and 4 weeks of follow-up) investigating the impact that Alkontrol-herbal has on alcohol intake in a population (age 21-60 years) seeking treatment for an alcohol use disorder. Participants will take 500 mg of a crude kudzu extract (NPI-031, Alkontrol-herbal; Natural Pharmacia International, Burlington, MA) t.i.d.; matched sugar beet placebo capsules will serve as placebo. Subjects will come to the lab three times a week to provide urine samples that can be tested for medication compliance through a biochemical marker, acetazolamide, included in the medication capsules. Participants will record their alcohol intake through daily diaries and a wrist actigraphy device, which will also monitor their sleep/wake activity.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTkudzu extract, puerarinCapsules containing 500 mg of a crude kudzu extract (NPI-031, Alkontrol-herbal; Natural Pharmacia International, Burlington, MA) will be used, containing 19% puerarin, 4% daidzin and 2% daidzein, so each capsule contains a total of 25% active isoflavones or 125 mg.
DIETARY_SUPPLEMENTPlacebo controlMatched sugar beet placebo capsules will serve as placebo.

Timeline

Start date
2018-01-01
Primary completion
2020-03-01
Completion
2020-07-01
First posted
2017-04-04
Last updated
2020-07-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03099590. Inclusion in this directory is not an endorsement.